197 related articles for article (PubMed ID: 31544947)
1. Fibroblast Activation Protein is a GH Target: A Prospective Study of Patients with Acromegaly Before and After Treatment.
Arlien-Søborg MC; Grøndahl C; Bæk A; Dal J; Madsen M; Høgild ML; Pedersen SB; Bjerre M; Jørgensen JOL
J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31544947
[TBL] [Abstract][Full Text] [Related]
2. FAP finds FGF21 easy to digest.
Gillum MP; Potthoff MJ
Biochem J; 2016 May; 473(9):1125-7. PubMed ID: 27118870
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21.
Dunshee DR; Bainbridge TW; Kljavin NM; Zavala-Solorio J; Schroeder AC; Chan R; Corpuz R; Wong M; Zhou W; Deshmukh G; Ly J; Sutherlin DP; Ernst JA; Sonoda J
J Biol Chem; 2016 Mar; 291(11):5986-5996. PubMed ID: 26797127
[TBL] [Abstract][Full Text] [Related]
4. Adipose tissue contribution to plasma fibroblast growth factor 21 and fibroblast activation protein in obesity.
van Baak MA; Vink RG; Roumans NJT; Cheng CC; Adams AC; Mariman ECM
Int J Obes (Lond); 2020 Feb; 44(2):544-547. PubMed ID: 31455871
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 21, fibroblast growth factor receptor 1, and β-Klotho expression in bovine growth hormone transgenic and growth hormone receptor knockout mice.
Brooks NE; Hjortebjerg R; Henry BE; List EO; Kopchick JJ; Berryman DE
Growth Horm IGF Res; 2016; 30-31():22-30. PubMed ID: 27585733
[TBL] [Abstract][Full Text] [Related]
6. Eccentric exercise increases circulating fibroblast activation protein α but not bioactive fibroblast growth factor 21 in healthy humans.
Parmar B; Lewis JE; Samms RJ; Ebling FJP; Cheng CC; Adams AC; Mallinson J; Cooper S; Taylor T; Ghasemi R; Stephens FB; Tsintzas K
Exp Physiol; 2018 Jun; 103(6):876-883. PubMed ID: 29663541
[TBL] [Abstract][Full Text] [Related]
7. The possible role of mRNA expression changes of GH/IGF-1/insulin axis components in subcutaneous adipose tissue in metabolic disturbances of patients with acromegaly.
Touskova V; Klouckova J; Durovcova V; Lacinova Z; Kavalkova P; Trachta P; Kosak M; Mraz M; Haluzikova D; Hana V; Marek J; Krsek M; Haluzik M
Physiol Res; 2016 Jul; 65(3):493-503. PubMed ID: 27070751
[TBL] [Abstract][Full Text] [Related]
8. FGF21 and glycemic control in patients with T1D.
Rosell Rask S; Krarup Hansen T; Bjerre M
Endocrine; 2019 Sep; 65(3):550-557. PubMed ID: 31372821
[TBL] [Abstract][Full Text] [Related]
9. Metformin Improves the Prerequisites for FGF21 Signaling in Patients With Type 2 Diabetes.
Pedersen AKN; Gormsen LC; Nielsen S; Jessen N; Bjerre M
J Clin Endocrinol Metab; 2024 Jan; 109(2):e552-e561. PubMed ID: 37776319
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory adipokines contribute to insulin resistance in active acromegaly and respond differently to different treatment modalities.
Olarescu NC; Ueland T; Godang K; Lindberg-Larsen R; Jørgensen JO; Bollerslev J
Eur J Endocrinol; 2014 Jan; 170(1):39-48. PubMed ID: 24092547
[TBL] [Abstract][Full Text] [Related]
11. Myokines in Acromegaly: An Altered Irisin Profile.
Mizera Ł; Halupczok-Żyła J; Kolačkov K; Zembska A; Grzegrzółka J; Jędrzejuk D; Bolanowski M; Daroszewski J
Front Endocrinol (Lausanne); 2021; 12():728734. PubMed ID: 34795636
[TBL] [Abstract][Full Text] [Related]
12. Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly.
Ueland T; Fougner SL; Godang K; Lekva T; Schurgers LJ; Scholz H; Halvorsen B; Schreiner T; Aukrust P; Bollerslev J
J Clin Endocrinol Metab; 2010 Jan; 95(1):361-8. PubMed ID: 19880791
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata.
Brokopp CE; Schoenauer R; Richards P; Bauer S; Lohmann C; Emmert MY; Weber B; Winnik S; Aikawa E; Graves K; Genoni M; Vogt P; Lüscher TF; Renner C; Hoerstrup SP; Matter CM
Eur Heart J; 2011 Nov; 32(21):2713-22. PubMed ID: 21292680
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
Dienus K; Bayat A; Gilmore BF; Seifert O
Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
[TBL] [Abstract][Full Text] [Related]
15. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.
Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F
Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368
[TBL] [Abstract][Full Text] [Related]
16. Higher serum levels of fibroblast growth factor 21 in old patients with cachexia.
Franz K; Ost M; Otten L; Herpich C; Coleman V; Endres AS; Klaus S; Müller-Werdan U; Norman K
Nutrition; 2019; 63-64():81-86. PubMed ID: 30933730
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.
Busek P; Balaziova E; Matrasova I; Hilser M; Tomas R; Syrucek M; Zemanova Z; Krepela E; Belacek J; Sedo A
Tumour Biol; 2016 Oct; 37(10):13961-13971. PubMed ID: 27492457
[TBL] [Abstract][Full Text] [Related]
18. Reduction in serum fibroblast growth factor-21 after gastric bypass is related to changes in hepatic fat content.
Fjeldborg K; Pedersen SB; Møller HJ; Richelsen B
Surg Obes Relat Dis; 2017 Sep; 13(9):1515-1523. PubMed ID: 28552744
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast activation protein is dispensable for control of glucose homeostasis and body weight in mice.
Panaro BL; Coppage AL; Beaudry JL; Varin EM; Kaur K; Lai JH; Wu W; Liu Y; Bachovchin WW; Drucker DJ
Mol Metab; 2019 Jan; 19():65-74. PubMed ID: 30477988
[TBL] [Abstract][Full Text] [Related]
20. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF
Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
